Search research articles
Contact Us
Filters
Showing results (131-140 of 1,929) with videos related to
Page
of 193
Sort By:
The New England Journal of Medicine
|
January 8, 2025
Combination Therapy for Chronic HBV Infection
Harry L A Janssen, Milan J Sonneveld
Journal of Hepatology
|
December 1, 2024
Reply to: "The incidence of hepatitis flare and hepatic decompensation after nucleos(t)ide analogue cessation in chronic hepatitis B patients"
Edo J Dongelmans, Harry L A Janssen
Plos One
|
July 18, 2015
Costs of Planned Home vs. Hospital Birth in British Columbia Attended by Registered Midwives and Physicians
Patricia A Janssen, Craig Mitton, Jaafar Aghajanian
Scandinavian Journal of Infectious Diseases. Supplementum
|
January 1, 1982
Treatment of helminthiasis
P A Janssen, H van den Bossche
Water Science and Technology : a Journal of the International Association on Water Pollution Research
|
October 4, 2002
Optimisation of control of river and sewage flows in the Great Culvert, England
R H A Janssen, S M Mills
Experimental & Applied Acarology
|
August 13, 2002
Predatory mites avoid ovipositing near counterattacking prey
F Faraji, A Janssen, M W Sabelis
Environmental Modelling & Software : with Environment Data News
|
September 22, 2020
On code sharing and model documentation of published individual and agent-based models
Marco A Janssen, Calvin Pritchard, Allen Lee
The New England Journal of Medicine
|
August 22, 2006
Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2
Sarwa Darwish Murad, Harry L A Janssen
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 6, 2011
Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?
Milan J Sonneveld, Harry L A Janssen
Journal of Hepatology
|
March 13, 2026
Is Partial Cure a Realistic Endpoint for Novel Hepatitis B Therapy? Reply to Chan et al
Milan J Sonneveld, Harry L A Janssen
Page
of 193
Search research articles
Search
Showing results (131-140 of 1,929) with videos related to
Sort By:
Page
of 193
The New England Journal of Medicine
|
January 8, 2025
Combination Therapy for Chronic HBV Infection
Harry L A Janssen, Milan J Sonneveld
Journal of Hepatology
|
December 1, 2024
Reply to: "The incidence of hepatitis flare and hepatic decompensation after nucleos(t)ide analogue cessation in chronic hepatitis B patients"
Edo J Dongelmans, Harry L A Janssen
Plos One
|
July 18, 2015
Costs of Planned Home vs. Hospital Birth in British Columbia Attended by Registered Midwives and Physicians
Patricia A Janssen, Craig Mitton, Jaafar Aghajanian
Scandinavian Journal of Infectious Diseases. Supplementum
|
January 1, 1982
Treatment of helminthiasis
P A Janssen, H van den Bossche
Water Science and Technology : a Journal of the International Association on Water Pollution Research
|
October 4, 2002
Optimisation of control of river and sewage flows in the Great Culvert, England
R H A Janssen, S M Mills
Experimental & Applied Acarology
|
August 13, 2002
Predatory mites avoid ovipositing near counterattacking prey
F Faraji, A Janssen, M W Sabelis
Environmental Modelling & Software : with Environment Data News
|
September 22, 2020
On code sharing and model documentation of published individual and agent-based models
Marco A Janssen, Calvin Pritchard, Allen Lee
The New England Journal of Medicine
|
August 22, 2006
Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2
Sarwa Darwish Murad, Harry L A Janssen
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 6, 2011
Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?
Milan J Sonneveld, Harry L A Janssen
Journal of Hepatology
|
March 13, 2026
Is Partial Cure a Realistic Endpoint for Novel Hepatitis B Therapy? Reply to Chan et al
Milan J Sonneveld, Harry L A Janssen
Page
of 193